San Francisco-based value-oriented investment manager specializing in long-only equity, fixed income and balanced strategies for institutional and retail clients. Dodge & Cox emphasizes bottom-up fundamental research, deep-conviction portfolios and a disciplined contrarian approach to valuation and risk. Known for low-turnover, concentrated holdings and multi-decade continuity in senior investment teams, the firm competes with global active managers in the value and income segments.
San Francisco-based value-oriented investment manager specializing in long-only equity, fixed income and balanced strategies for institutional and retail clients. Dodge & Cox emphasizes bottom-up fundamental research, deep-conviction portfolios and a disciplined contrarian approach to valuation and risk. Known for low-turnover, concentrated holdings and multi-decade continuity in senior investment teams, the firm competes with global active managers in the value and income segments.
Value-driven, long-term capital allocator focused on high-conviction, low-turnover equity and fixed-income positions across institutional and retail mandates. Investment decisions are grounded in bottom-up fundamental research, rigorous valuation discipline and a contrarian lens that seeks mispriced securities and durable cash flows. Portfolios emphasize concentrated holdings, income generation and risk control via duration and quality selection in credit. Governance favors team continuity, internal accountability and an underwriting bias toward deep research edge rather than market timing.
Value-driven, long-term capital allocator focused on high-conviction, low-turnover equity and fixed-income positions across institutional and retail mandates. Investment decisions are grounded in bottom-up fundamental research, rigorous valuation discipline and a contrarian lens that seeks mispriced securities and durable cash flows. Portfolios emphasize concentrated holdings, income generation and risk control via duration and quality selection in credit. Governance favors team continuity, internal accountability and an underwriting bias toward deep research edge rather than market timing.
| Trades 17476 | Longs Won 12396/17476 70% | Profit Factor 3.81 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $78.02M |
| Average Win $23.4M | Best Trade (Aug 19) $1.76B | Sharpe Ratio -28.77 |
| Average Loss -$15M | Worst Trade (Mar 31) -$1.48B | Z-Score -11.06 (100%) |
| Commissions $0 | Avg. Trade Length 4y 6m 2w 5d | Expectancy $12.24M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 13,514 | 12,162 | 10,811 | 9,459 | 8,108 | 6,757 | 5,405 | 4,054 | 2,703 | 1,351 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 31,382 | $3.28M | $9.58M | - | $6.3M | 192.43% | +0.996% |
ABBV AbbVie Inc. | 10,393 | $553,384.54 | $2.59M | - | $2.03M | 367.19% | 0.0 |
ABEV Ambev S.A. | 252,700 | $522,653 | $712,614 | - | $189,961 | 36.35% | 0.0 |
ABT Abbott Laboratories | 17,324 | $755,673.11 | $1.92M | - | $1.17M | 154.26% | 0.0 |
ACMR Acm Research Inc. | 116,392 | $3.37M | $9.46M | - | $6.09M | 180.88% | 0.0 |
ADBE Adobe Inc. | 3.11M | $963.9M | $805.99M | - | -$157.91M | -16.38% | 0.0 |
ADI Analog Devices, Inc. | 19,210 | $3.22M | $7.38M | - | $4.17M | 129.55% | 0.0 |
ADM Archer-Daniels-Midland Co | 14.18M | $817.33M | $1.13B | - | $313.43M | 38.35% | 0.0 |
AEG Aegon N.V. | 44.64M | $257.18M | $419.57M | - | $162.39M | 63.14% | 0.0 |
AEP American Electric Power Company, Inc. | 8.67M | $747.63M | $1.08B | - | $333.63M | 44.63% | 0.0 |
AFYA Afya Ltd. | 51,287 | $696,878.82 | $704,683.38 | - | $7,804.56 | 1.12% | 0.0 |
AJG Arthur J. Gallagher & Co. | 9.36M | $2.09B | $2.39B | - | $300.8M | 14.38% | 0.0 |
ALL Allstate Corporation | 2,595 | $102,776.88 | $663,904.8 | - | $561,127.92 | 545.97% | 0.0 |
ALNY Alnylam Pharmaceuticals Inc | 1.96M | $280.54M | $437.91M | - | $157.37M | 56.1% | 0.0 |
AMG Affiliated Managers Group Inc. | 600 | $203,040 | $217,440 | - | $14,400 | 7.09% | 0.0 |
AMGN Amgen Inc. | 12,817 | $781,000.88 | $5.33M | - | $4.55M | 582.99% | 0.0 |
AMP Ameriprise Financial, Inc. | 1,500 | $78,248.78 | $847,605 | - | $769,356.22 | 983.22% | 0.0 |
AMZN Amazon.com Inc | 16.71M | $1.9B | $4.47B | - | $2.57B | 135.35% | 0.0 |
AON Aon plc | 8.59M | $3.03B | $3.03B | - | $756,354.3 | 0.02% | 0.0 |
APA APA Corporation | 19,500 | $349,049.79 | $779,415 | - | $430,365.21 | 123.3% | 0.0 |